Foldrx Pharmaceuticals' Series C Round

Foldrx Pharmaceuticals raised a round of funding on June 11, 2010.

FoldRx is a leader in the discovery and development of disease-modifying drug therapies for diseases of protein misfolding and amyloidosis.…

Articles about Foldrx Pharmaceuticals' Series C Round: